Your browser doesn't support javascript.
Building the National SARS-CoV-2 Laboratory Diagnostic Capacity in Taiwan.
Yang, Ji-Rong; Liu, Ming-Tsan; Huang, Hsin-I; Teng, Hwa-Jen; Chen, Jou-Han; Li, Shu-Ying.
  • Yang JR; Ji-Rong Yang, PhD, is a Technical Specialist, and Ming-Tsan Liu, PhD, is a Researcher and Primary Investigator, in the Viral Respiratory Diseases Laboratory; Hwa-Jen Teng, PhD, is Section Chief, and Jou-Han Chen is an Assistant Researcher, in the Laboratory Quality Assurance and Biosafety Section; H
  • Liu MT; Ji-Rong Yang, PhD, is a Technical Specialist, and Ming-Tsan Liu, PhD, is a Researcher and Primary Investigator, in the Viral Respiratory Diseases Laboratory; Hwa-Jen Teng, PhD, is Section Chief, and Jou-Han Chen is an Assistant Researcher, in the Laboratory Quality Assurance and Biosafety Section; H
  • Huang HI; Ji-Rong Yang, PhD, is a Technical Specialist, and Ming-Tsan Liu, PhD, is a Researcher and Primary Investigator, in the Viral Respiratory Diseases Laboratory; Hwa-Jen Teng, PhD, is Section Chief, and Jou-Han Chen is an Assistant Researcher, in the Laboratory Quality Assurance and Biosafety Section; H
  • Teng HJ; Ji-Rong Yang, PhD, is a Technical Specialist, and Ming-Tsan Liu, PhD, is a Researcher and Primary Investigator, in the Viral Respiratory Diseases Laboratory; Hwa-Jen Teng, PhD, is Section Chief, and Jou-Han Chen is an Assistant Researcher, in the Laboratory Quality Assurance and Biosafety Section; H
  • Chen JH; Ji-Rong Yang, PhD, is a Technical Specialist, and Ming-Tsan Liu, PhD, is a Researcher and Primary Investigator, in the Viral Respiratory Diseases Laboratory; Hwa-Jen Teng, PhD, is Section Chief, and Jou-Han Chen is an Assistant Researcher, in the Laboratory Quality Assurance and Biosafety Section; H
  • Li SY; Ji-Rong Yang, PhD, is a Technical Specialist, and Ming-Tsan Liu, PhD, is a Researcher and Primary Investigator, in the Viral Respiratory Diseases Laboratory; Hwa-Jen Teng, PhD, is Section Chief, and Jou-Han Chen is an Assistant Researcher, in the Laboratory Quality Assurance and Biosafety Section; H
Health Secur ; 2020 Aug 19.
Article in English | MEDLINE | ID: covidwho-725856
ABSTRACT
Through early and proactive laboratory testing of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes novel coronavirus 2019, Taiwan has demonstrated an efficient and rapid control response to contain the outbreak. Two days after the World Health Organization announced the complete viral genome sequence, the national laboratory of the Taiwan Centers for Disease Control developed a specific real-time reverse transcription polymerase chain reaction (real-time RT-PCR) test for SARS-CoV-2. The national laboratory network was further strengthened through the recruitment of medical centers and regional hospitals distributed throughout most geographical regions of the country. Ultimately, a network of 60 laboratories with a capacity of 7,342 real-time RT-PCR tests per day was established. Between January 14 and August 5, 2020, a total of 158,772 tests were conducted, corresponding to 120,487 cases. Test results were obtained within 24 hours, enabling an efficient and rapid control response.
Keywords

Full text: Available Collection: International databases Database: MEDLINE Type of study: Diagnostic study / Observational study Language: English Year: 2020 Document Type: Article

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Type of study: Diagnostic study / Observational study Language: English Year: 2020 Document Type: Article